A monthly wrap-up of the Endocrine Society’s Advocacy efforts on behalf of the practice and science of endocrinology in the U.S. and around the world. Short-term Extension of SDP and Telehealth Waivers Signed into Law On December 21, 2024, President Biden signed into law a slimmed-down, temporary government spending bill to avoid a government shutdown....
Congress Returns to Washington for “Lame Duck” Session and to Complete Work for 2024 Following the November elections, Congress will return to Washington, D.C., to complete work on federal funding and a package of several pieces of health legislation including many priorities of the Endocrine Society. Federal funding for the government expires December 20, 2024,...
Endocrine Society Endorses Right to IVF Act In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families...
Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow...
Society Advocates for Protecting Access to IVF Treatment and PFAS Education at AMA Annual Meeting
In June, Endocrine Society members Salwa Zahalka, MD; Palak Choksi, MD; Mandy Bell, MD; and Dan Spratt, MD; who serve as the Society’s delegation to the American Medical Association’s (AMA) House of Delegates, attended the AMA meeting in Chicago to advocate for policies important to our members. The AMA House of Delegates meets twice a...
Society Advocates for Access to Diabetes and Obesity Medications; Meets with FDA to Discuss Current Prescription Drug Shortages Over the past several months, the Endocrine Society has advocated for improving access to diabetes and obesity medications amid ongoing drug shortages that have impacted the country. The Society has heard from our members that they are...
Endocrine Society Advocates to Protect and Increase Funding for the NIH On March 5, the Endocrine Society will conduct a Researcher Hill Day to advocate for the importance of the National Institutes of Health (NIH). We are asking Congress to complete work on a funding bill for the remainder of fiscal year (FY) 2024, before...
The Endocrine Society is advocating for you. In 2023 we achieved several important advocacy accomplishments, including: All these accomplishments were achieved because our members participated in our advocacy activities, online campaigns, Hill Days, and meetings with policymakers. Below are some examples of our advocacy victories. Advocacy to Lower the Cost of Insulin – The Endocrine Society...
